Ontology highlight
ABSTRACT:
PROVIDER: PRJNA686138 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR13269407.fastq.gz | Fastqsanger.gz | |||
| SRR13269408.fastq.gz | Fastqsanger.gz | |||
| SRR13269409.fastq.gz | Fastqsanger.gz | |||
| SRR13269410.fastq.gz | Fastqsanger.gz | |||
| SRR13269411.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 10 |
Shared Molecules
Only show the datasets with similarity scores above: 0.5
Threshold
0.5
Similar Datasets
Project description:High throughput sequencing of polyA-RNAs in HIV treated patients and healthy controls
2025-01-16 | E-MTAB-8249 | ExpressionAtlas
Project description:Coronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic strategies. Platelets play a major role, not only in the process of acute thrombosis during plaque rupture, but also in the formation of atherosclerosis itself. MicroRNAs are endogenous small non-coding RNAs that control gene expression and are expressed in a tissue and disease-specific manner. Therefore they have been proposed to be useful biomarkers. It remains unknown whether differences in miRNA expression levels in platelets can be found between patients with premature CAD and healthy controls. Methodology/Principal Findings In this case-control study we measured relative expression levels of platelet miRNAs using microarrays from 12 patients with premature CAD and 12 age- and sex-matched healthy controls. Six platelet microRNAs were significantly upregulated (miR340*, miR451, miR454*, miR545:9.1. miR615-5p and miR624*) and one miRNA (miR1280) was significantly downregulated in patients with CAD as compared to healthy controls. To validate these results, we measured the expression levels of these candidate miRNAs by qRT-PCR in platelets of individuals from two independent cohorts; validation cohort I consisted of 40 patients with premature CAD and 40 healthy controls and validation cohort II consisted of 27 patients with artery disease and 40 healthy relatives. MiR340* and miR624* were confirmed to be upregulated in patients with CAD as compared to healthy controls in both validation cohorts. Conclusion/Significance Two miRNAs in platelets are significantly upregulated in patients with CAD as compared to healthy controls.
2011-10-01 | GSE28858 | GEO
Project description:Transcription profiling by 3'-end sequencing of whole blood from pancreatic ductal adenocarcinoma (PDAC) patients and healthy controls for PDAC diagnosis
2025-01-23 | E-MTAB-3823 | ExpressionAtlas
Project description:Coronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic strategies. Platelets play a major role, not only in the process of acute thrombosis during plaque rupture, but also in the formation of atherosclerosis itself. MicroRNAs are endogenous small non-coding RNAs that control gene expression and are expressed in a tissue and disease-specific manner. Therefore they have been proposed to be useful biomarkers. It remains unknown whether differences in miRNA expression levels in platelets can be found between patients with premature CAD and healthy controls. Methodology/Principal Findings In this case-control study we measured relative expression levels of platelet miRNAs using microarrays from 12 patients with premature CAD and 12 age- and sex-matched healthy controls. Six platelet microRNAs were significantly upregulated (miR340*, miR451, miR454*, miR545:9.1. miR615-5p and miR624*) and one miRNA (miR1280) was significantly downregulated in patients with CAD as compared to healthy controls. To validate these results, we measured the expression levels of these candidate miRNAs by qRT-PCR in platelets of individuals from two independent cohorts; validation cohort I consisted of 40 patients with premature CAD and 40 healthy controls and validation cohort II consisted of 27 patients with artery disease and 40 healthy relatives. MiR340* and miR624* were confirmed to be upregulated in patients with CAD as compared to healthy controls in both validation cohorts. Conclusion/Significance Two miRNAs in platelets are significantly upregulated in patients with CAD as compared to healthy controls. miRNA array analysis of isolated platelets from subjects with premature coronary artery disease compared to healthy control subjects.
2011-09-30 | E-GEOD-28858 | biostudies-arrayexpress
Project description:RNA-seq of blood from 105 patients with brucellosis, 17 patients with Leishmaniasis and 47 healthy controls
2025-01-24 | E-GEOD-69597 | ExpressionAtlas
Project description:Gene expression profiles of fibroblasts from childhood cerebral adrenoleukodystrophy patients and healthy controls
2025-01-24 | E-GEOD-34308 | ExpressionAtlas
Project description:Expression data from uremic patients (end stage renal failure) and 20 healthy controls
2025-01-24 | E-GEOD-37171 | ExpressionAtlas
Project description:Transcription profiling by array of skin biopsies from dermatomyositis patients and healthy controls
2025-01-24 | E-GEOD-46239 | ExpressionAtlas
Project description:Microarray analysis of blood of 40 sporadic Parkinson's disease patients and 20 healthy controls
2025-01-24 | E-GEOD-72267 | ExpressionAtlas
Project description:Total transcriptome and gene expression profile of peripheral blood mononuclear cells (PMBCs) from 5 patients with CAD and 5 healthy controls were analyzed by RNA sequencing.
2023-06-21 | GSE205255 | GEO